Cargando…
An update on the management of antiphospholipid syndrome
Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by recurrent venous or arterial thrombosis with or without pregnancy morbidity in the presence of persistent antiphospholipid (aPL) autoantibodies. Anticoagulation has, until now, formed the cornerstone of treatment but...
Autores principales: | Rodziewicz, Mia, D’Cruz, David P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236388/ https://www.ncbi.nlm.nih.gov/pubmed/32523633 http://dx.doi.org/10.1177/1759720X20910855 |
Ejemplares similares
-
Antiphospholipid (Hughes) Syndrome: An Overview
por: D’Cruz, David P.
Publicado: (2006) -
Controversies in the antiphospholipid syndrome: can we ever stop warfarin?
por: Fonseca, Ana G, et al.
Publicado: (2008) -
Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis
por: Mialdea, Maria, et al.
Publicado: (2009) -
Management of Antiphospholipid Syndrome
por: Ghembaza, Amine, et al.
Publicado: (2020) -
Management of the antiphospholipid syndrome
por: Espinosa, Gerard, et al.
Publicado: (2010)